Abstract

Case Report

A Complex Case with a Completely Percutaneous Solution: Treatment of a Severe Calcific Left Main in a Patient with Low-Flow Low-Gradient Aortic Stenosis

Renatomaria Bianchi*, Giovanni Marco Esposito, Giovanni Ciccarelli, Donato Tartaglione and Paolo Golino

Published: 02 April, 2024 | Volume 9 - Issue 1 | Pages: 061-066

Background: This case study explores an integrated approach to managing a complex cardiac condition, presenting a comprehensive single-session intervention. This includes balloon valvuloplasty using a Nucleus 18 mm balloon, complex angioplasty with rotational atherectomy (rotablator) targeting calcified lesions in the left main and left anterior descending artery, and Transcatheter Aortic Valve Implantation (TAVI) with a 23 mm Sapien 3 valve, all performed on an 81-year-old woman. Furthermore, this report underscores the strategic left atrial appendage closure conducted three months post-procedure due to the patient’s elevated hemorrhagic risk.
Case presentation: Facing critical coronary and valvular pathologies, the patient underwent a meticulously planned, single-session intervention. The process began with a balloon valvuloplasty using a Nucleus 18 mm balloon to address the aortic stenosis. This was followed by a high-risk angioplasty, during which the Impella CP device provided hemodynamic support and rotational atherectomy was employed to address the calcified coronary artery disease effectively. The same session saw the successful execution of TAVI using a 23 mm Sapien 3 valve. The comprehensive approach notably diminished procedural complications, illustrating the benefits of an integrated treatment pathway in managing high-risk patients. Three months later, the patient underwent a left atrial appendage closure, a critical move considering her high risk of hemorrhage. This procedure also provided an opportunity to assess the favorable outcomes of the previous angioplasty.
Conclusion: This case validates the feasibility and efficacy of performing multiple advanced percutaneous interventions in a single session for high-risk cardiac patients. It underscores the crucial role of innovative and personalized treatment strategies in improving patient outcomes, particularly in complex clinical scenarios. Moreover, the case exemplifies the essential relationship between immediate, comprehensive intervention and subsequent follow-up procedures in ensuring optimal long-term patient care.

Read Full Article HTML DOI: 10.29328/journal.jccm.1001180 Cite this Article Read Full Article PDF

Keywords:

Coronary artery disease; Aortic stenosis; TAVI; Left atrial appendage Closure; Complex High-risk Coronary Procedure (CHIP); Ventricular support; Rotational atherectomy

References

  1. Vahanian A, Beyersdorf F, Praz F, Milojevic M, Baldus S, Bauersachs J, Capodanno D, Conradi L, Bonis MD, Paulis RD, Delgado V, Freemantle N, Gilard M, Haugaa K, Jeppsson A, Jüni P, Pierard L, Prendergast BD, Sádaba JR, Tribouilloy C, Wojakowski W. ESC/EACTS Scientific Document Group , ESC National Cardiac Societies , 2021 ESC/EACTS Guidelines for the management of valvular heart disease: Developed by the Task Force for the management of valvular heart disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS), European Heart Journal. 2022; 43 (7): 561-63.
  2. Thygesen K, Alpert JS, Jaffe AS, Chaitman BR, Bax JJ, Morrow DA, White HD. ESC Scientific Document Group, Fourth universal definition of myocardial infarction (2018). European Heart Journal. 2019; 40 (3):237-269. https://doi.org/10.1093/eurheartj/ehy462
  3. Neumann FJ, Uva MS, Ahlsson A, Alfonso F, Banning AP, Benedetto U, Byrne RA, Collet JP, Falk, Stuart JH, Peter J, Kastrati A, Koller A, Kristensen SD, Niebauer J, Richter DJ, Seferović PM, Sibbing D, Stefanini GG, Windecker S, Yadav R, Zembala MO. ESC Scientific Document Group. 2019; 40 (2): 87-165. https://doi.org/10.1093/eurheartj/ehy394
  4. Mousa MAA, Bingen BO, Al Amri I, Mertens BJA, Taha S, Tohamy A, Youssef A, Jukema JW, Montero-Cabezas JM. Efficacy and Safety of Intravascular Lithotripsy Versus Rotational Atherectomy in Balloon-Crossable Heavily Calcified Coronary Lesions. Cardiovasc Revasc Med. 2023 Mar;48:1-6. doi: 10.1016/j.carrev.2022.10.011. Epub 2022 Oct 29. PMID: 36336588.
  5. Diaz Quintero L, Gajo E, Guerrero M, Feldman T, Levisay J. Balloon Aortic Valvuloplasty Followed by Impella®-Assisted Left Main Coronary Artery Percutaneous Coronary Intervention in Patients with Severe Aortic Stenosis as a Bridge to Transcatheter Aortic Valve Replacement. Cardiovasc Revasc Med. 2021 Jan; 22:16-21. doi: 10.1016/j.carrev.2020.06.003. Epub 2020 Jun 3. PMID: 32532627.
  6. Spiro J, Venugopal V, Raja Y, Ludman PF, Townend JN, Doshi SN. Feasibility and efficacy of the 2.5 L and 3.8 L impella percutaneous left ventricular support device during high-risk, percutaneous coronary intervention in patients with severe aortic stenosis. Catheter Cardiovasc Interv. 2015 May;85(6):981-9. doi: 10.1002/ccd.25355. Epub 2014 Jan 31. PMID: 24408882.
  7. Kneizeh K, Alnaimi A, Noterdaeme T, Schröder J, Altiok E, Marx N, Almalla M. Protected Percutaneous Coronary Intervention of Unprotected Left Main Using Impella Ventricular Assist Device Before Transcatheter Aortic Valve Implantation: A Single-Center Experience. J Invasive Cardiol. 2022 Mar;34(3):E196-E201. Epub 2022 Jan 20. PMID: 35058376.
  8. Penkalla A, Pasic M, Drews T, Buz S, Dreysse S, Kukucka M, Mladenow A, Hetzer R, Unbehaun A. Transcatheter aortic valve implantation combined with elective coronary artery stenting: a simultaneous approach†. Eur J Cardiothorac Surg. 2015 Jun;47(6):1083-9. doi: 10.1093/ejcts/ezu339. Epub 2014 Sep 12. PMID: 25217500.
  9. Holmes DR Jr, Korsholm K, Rodés-Cabau J, Saw J, Berti S, Alkhouli MA. Left atrial appendage occlusion. EuroIntervention. 2023 Feb 6;18(13):e1038-e1065. doi: 10.4244/EIJ-D-22-00627. PMID: 36760206; PMCID: PMC9909459.
  10. Valgimigli M, Bueno H, Byrne RA, Jean-Philippe C, Costa F, Jeppsson A, Jüni P, Kastrati A, Kolh P, Mauri L, Montalescot G, Neumann FJ, Petricevic M, Roffi M, Steg PG, Windecker S, Zamorano JL, Levine GN. ESC Scientific Document Group , ESC Committee for Practice Guidelines (CPG) , ESC National Cardiac Societies , 2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS: The Task Force for dual antiplatelet therapy in coronary artery disease of the European Society of Cardiology (ESC) and of the European Association for Cardio-Thoracic Surgery (EACTS), European Heart Journal. 2018; 39 (3): 213-260.
  11. Lopes RD, Vora AN, Liaw D, Granger CB, Darius H, Goodman SG, Mehran R, Windecker S, Alexander JH. An open-Label, 2 × 2 factorial, randomized controlled trial to evaluate the safety of apixaban vs. vitamin K antagonist and aspirin vs. placebo in patients with atrial fibrillation and acute coronary syndrome and/or percutaneous coronary intervention: Rationale and design of the AUGUSTUS trial. Am Heart J. 2018 Jun;200:17-23. doi: 10.1016/j.ahj.2018.03.001. Epub 2018 Mar 9. PMID: 29898844.
  12. Lopes RD, Heizer G, Aronson R, Vora AN, Massaro T, Mehran R, Goodman SG, Windecker S, Darius H, Li J, Averkov O, Bahit MC, Berwanger O, Budaj A, Hijazi Z, Parkhomenko A, Sinnaeve P, Storey RF, Thiele H, Vinereanu D, Granger CB, Alexander JH; AUGUSTUS Investigators. Antithrombotic Therapy after Acute Coronary Syndrome or PCI in Atrial Fibrillation. N Engl J Med. 2019 Apr 18;380(16):1509-1524. doi: 10.1056/NEJMoa1817083. Epub 2019 Mar 17. PMID: 30883055.

Figures:

Similar Articles

Recently Viewed

  • Statistical Mathematical Analysis of COVID-19 at World Level
    Marín-Machuca Olegario*, Carlos Enrique Chinchay-Barragán, Moro-Pisco José Francisco, Vargas-Ayala Jessica Blanca, Machuca-Mines José Ambrosio, María del Pilar Rojas-Rueda and Zambrano-Cabanillas Abel Walter Marín-Machuca Olegario*, Carlos Enrique Chinchay-Barragán, Moro-Pisco José Francisco, Vargas-Ayala Jessica Blanca, Machuca-Mines José Ambrosio, María del Pilar Rojas-Rueda, Zambrano-Cabanillas Abel Walter. Statistical Mathematical Analysis of COVID-19 at World Level. Int J Phys Res Appl. 2024: doi: 10.29328/journal.ijpra.1001082; 7: 040-047
  • A fatal portal vein thrombosis: A case report
    M Kechida*, W Ben Yahia and W Mnari M Kechida*,W Ben Yahia,W Mnari. A fatal portal vein thrombosis: A case report. Arch Vas Med. 2019: doi: 10.29328/journal.avm.1001009; 3: 007-008
  • Oral Cancer Management is not just Treatment! But also, how early Pre-cancerous Lesions are Diagnosed & Treated!!
    Suresh Kishanrao* Suresh Kishanrao*. Oral Cancer Management is not just Treatment! But also, how early Pre-cancerous Lesions are Diagnosed & Treated!!. Arch Cancer Sci Ther. 2024: doi: 10.29328/journal.acst.1001039; 8: 007-012
  • Unusual and severe peripartum cardiomyopathy: A case report
    Lamanna B*, Vinciguerra M, Crupano FM, Cicinelli R, Cicinelli E and Vimercati A Lamanna B*,Vinciguerra M,Crupano FM,Cicinelli R,Cicinelli E,Vimercati A. Unusual and severe peripartum cardiomyopathy: A case report. J Cardiol Cardiovasc Med. 2021: doi: 10.29328/journal.jccm.1001116; 6: 040-043
  • Extracorporeal Membrane Oxygenation in Acute Aluminum Phosphide (AlP) Poisoning
    Oussama Ssouni*, Latifa Oualili, Tarek Dendane, Amine Ali Zeggwagh and Khalid Abidi Oussama Ssouni*, Latifa Oualili, Tarek Dendane, Amine Ali Zeggwagh, Khalid Abidi. Extracorporeal Membrane Oxygenation in Acute Aluminum Phosphide (AlP) Poisoning. Arch Surg Clin Res. 2023: doi: 10.29328/journal.ascr.1001071; 7: 024-034

Read More

Most Viewed

Read More

Help ?